B. V. Subba Reddy et al. / Tetrahedron Letters 54 (2013) 4960–4962
4961
O
highly stereoselective manner. Our approach involves mainly a
Prins/Ritter amidation followed by a reductive ring opening se-
quence. It is a modular approach, which can also be employed
for the synthesis of several piperidine alkaloid analogs.
HN
O
R
R
OH HN
HN
OH
I
R
1
6
7
O
Acknowledgements
O
B.P.R. and P.S.R.K.R. thank CSIR and Y.J.S.R. thank UGC, New Del-
hi, for the award of fellowships.
HN
CN
R
H
O
+
OTs
OTs
HO
R
O
References and notes
5
Scheme 1. Retrosynthetic analysis of (+)-8-ethylnorlobelol (1).
OH
OH
i
OTs
HN
OH
3
2
O
O
HN
ii
iii
I
OTs
O
6
O
5
iv
v
TBSO HN
8
OH HN
7
O
O
vii
ix
vi
TBSO HN
10
TBSO HN
9
O
O
viii
OH HN
11
OH HN
1
O
11. Analytical data for ((2R,4R,6S)-4-(acrylamido)-6-ethyl-tetrahydro-2H-pyran-2-
Scheme 2. Reagents and conditions: (i) Et3N, dibutyltin oxide, TsCl, DCM, rt, 1 h; (ii)
n-propanaldehyde, acrylonitrile, BF3.OEt2 (10 mol%), rt, 1 h; (iii) NaI, acetone, reflux,
6 h (iv) Zn dust, EtOH, reflux, 5 h; (v) TBSOTf, 2,6-lutidine, CH2Cl2, 10 min; (vi)
Grubb’s I catalyst (5 mol%), DCM, rt, 8 h; (vii) Pd/C, MeOH, Et3N, H2 (1 atm), 4 h;
(viii) TBAF, THF, rt, 3 h; (ix) LiAlH4, Et2O, reflux, 2 h.
yl)methyl-4-methylbenzenesulfonate: ½ ꢁ
a 2D5 +16.7 (c 1.0, CHCl3); 1H NMR
(300 MHz, CDCl3): d 7.78 (d, J = 8.3 Hz, 2H), 7.33 (d, J = 8.3 Hz, 2H), 6.22–6.33
(m, 1H), 5.98–6.10 (m, 1H), 5.63–5.69 (m, 1H), 5.41 (br s, 1H), 3.92–4.12 (m,
3H), 3.53–3.66 (m, 1H), 3.20–3.31 (m, 1H), 2.44 (s, 3H), 1.85–2.06 (m, 2H),
1.34–1.57 (m, 2H), 0.93–1.56 (m, 3H), 0.88 (t, J = 6.7 Hz, 3H); 13C NMR
(75 MHz, CDCl3): d 164.7, 144.6, 132.2, 130.6, 129.5, 127.5, 126.0, 75.8, 72.8,
71.5, 45.4, 37.5, 37.1, 33.1, 20.1, 10.7; IR (KBr)m3281, 3065, 2928, 1660, 1625,
1542, 1359, 1177, 982, 814, 668 cmꢂ1; HRMS (m/z) calcd for C18H26NO5S
lobelol (1). The hydroxyl group of compound 7 was then protected
as its TBS ether 8 in 95% yield using TBSOTf in the presence of 2,6-
lutidine.9 Compound 8 was then subjected to ring closing metath-
368.1531, found: 368.1540.
N-((4S,6S)-6-Hydroxyoct-1-en-4-yl)acrylamide: ½a D25
ꢁ
+9.3 (c 1.0, CHCl3); 1H NMR
(300 MHz, CDCl3): d 6.27–6.41 (m, 1H), 6.04–6.20 (m, 1H), 5.66–5.92 (m, 2H),
5.60 (d, J = 8.3 Hz, 1H), 5.09–5.20 (m, 2H), 4.29–4.44 (m, 1H), 3.49–3.61 (m,
1H), 2.22–2.41 (m, 2H), 1.23–1.64 (m, 5H), 0.89 (t, J = 7.5 Hz, 3H); 13C NMR
(75 MHz, CDCl3): d 166.5, 134.0, 130.2, 126.9, 117.9, 67.0, 46.0, 42.9, 39.1, 30.0,
esis using Grubb’s-I catalyst (5 mol%) in DCM to furnish a,b-unsat-
urated-d-lactam 9 in 98% yield.10 Reduction of olefin in compound
9 using palladium on carbon in methanol gave d-lactam 10 in 93%
yield. Deprotection of silyl ether 10 using TBAF in THF gave the
desilylated d-lactam 11 in 95% yield. Finally, the reduction of d-lac-
tam 11 with LiAlH4 in refluxing diethyl ether gave the target mol-
ecule, (+)-8-ethylnorlobelol (1) in 83% yield. The data of synthetic
(+)-8-ethylnorlobelol were in good agreement with the data re-
ported in the literature.11
20.9, 10.0; IR (KBr)
m3319, 3077, 2967, 1655, 1540, 1439, 1321, 1147, 987,
764 cmꢂ1; HRMS (m/z) calcd for C11H20NO2 198.1494, found: 198.1503.
N-((4S,6S)-6-((tert-Butyldimethylsilyl)oxy)oct-1-en-4-yl)acrylamide: ½ ꢁ +20.6
a 2D5
(c 0.4, CHCl3); 1H NMR (300 MHz, CDCl3): d 6.17–6.30 (m, 1H), 5.94–6.13 (m,
2H), 5.66–5.87 (m, 1H), 5.55–5.61 (m, 1H), 4.99–5.13 (m, 2H), 4.01–4.14 (m,
1H), 3.76–3.88 (m, 1H), 2.21–2.47 (m, 2H), 1.56–1.73 (m, 2H), 1.45–1.50 (m,
3H), 0.93 (s, 9H), 0.86 (t, J = 7.5 Hz, 3H), 0.09 (s, 3H), 0.07 (s, 3H); 13C NMR
(75 MHz, CDCl3): d 164.9, 134.4, 131.1, 125.7, 117.5, 70.2, 46.7, 39.0, 20.8, 10.1,
ꢂ4.4, ꢂ4.5; IR (KBr)
m
;
3276, 3074, 2956, 1657, 1626, 1547, 1465, 1254, 1072,
HRMS (m/z) calcd for C17H34NO2Si 312.2358, found:
911, 773, 665 cmꢂ1
312.2363.
In conclusion, an efficient approach has been developed for the
total synthesis of piperidine alkaloid, (+)-8-ethylnorlobelol (1) in a
(R)-6-((S)-2-((tert-Butyldimethylsilyl)oxy)butyl)-5,6-dihydropyridin-2-(1H)-one: